Undervalued Health care stocks, tonight
Drugs, devices, hospitals, and insurers. Skip if you do not follow biotech.
122 companies match
- DavitaDVA
DaVita provides dialysis and kidney care services to people with kidney disease.
- Market value
- $11.6bn
- Cash yield
- 11.3%
- Price to profit
- 7.5×
- Return on capital
- n/a
- Funds
- 3
- Score
- 1.22
- InnovivaINVA
Innoviva sells hospital drugs to hospitals and earns royalties from GSK.
- Market value
- $1.5bn
- Cash yield
- 13.1%
- Price to profit
- 7.3×
- Return on capital
- 20.7%
- Funds
- 2
- Score
- 1.15
- Boston ScientificBSX
BSX sells medical devices to hospitals, doctors, and healthcare providers.
- Market value
- $62.3bn
- Cash yield
- 5.9%
- Price to profit
- 17.8×
- Return on capital
- n/a
- Funds
- 3
- Score
- 1.05
- ExelixisEXEL
Exelixis sells cancer drugs to patients with kidney, liver, and colorectal cancer.
- Market value
- $13.9bn
- Cash yield
- 6.3%
- Price to profit
- 15.4×
- Return on capital
- n/a
- Funds
- 2
- Score
- 1.05
- Harmony Biosciences Holdings, inc.HRMY
Harmony Biosciences sells narcolepsy medicine to patients with sleep disorders.
- Market value
- $2.4bn
- Cash yield
- 14.4%
- Price to profit
- 8.7×
- Return on capital
- 18.3%
- Funds
- 0
- Score
- 1.00
- Puma BiotechnologyPBYI
Puma Biotechnology sells cancer drugs to patients with HER2-positive breast cancer.
- Market value
- $471m
- Cash yield
- 8.9%
- Price to profit
- 11.8×
- Return on capital
- 21.5%
- Funds
- 1
- Score
- 0.98
- Nutex HealthNUTX
Nutex Health sells hospital and doctor care to patients and insurers.
- Market value
- $1.4bn
- Cash yield
- 17.9%
- Price to profit
- 4.4×
- Return on capital
- 60.7%
- Funds
- 1
- Score
- 0.96
- Amphastar PharmaceuticalsAMPH
Amphastar sells generic injectable, inhalation, and nasal medicines to hospitals and patients.
- Market value
- $1.0bn
- Cash yield
- 12.0%
- Price to profit
- 10.4×
- Return on capital
- n/a
- Funds
- 0
- Score
- 0.95
- ResMedRMD
ResMed sells sleep apnea devices, ventilators, masks, and software to patients, clinics, and hospitals.
- Market value
- $31.5bn
- Cash yield
- 5.2%
- Price to profit
- 16.5×
- Return on capital
- n/a
- Funds
- 2
- Score
- 0.93
- GE Healthcare TechnologiesGEHC
GE HealthCare sells medical devices, software, and services to hospitals and researchers.
- Market value
- $28.9bn
- Cash yield
- 5.2%
- Price to profit
- 12.3×
- Return on capital
- 11.8%
- Funds
- 1
- Score
- 0.90
- Prestige Consumer HealthcarePBH
PBH sells packaged foods and cereals to grocery retailers and consumers.
- Market value
- $2.2bn
- Cash yield
- 11.1%
- Price to profit
- 10.6×
- Return on capital
- 8.5%
- Funds
- 0
- Score
- 0.89
- NU Skin EnterprisesNUS
Nu Skin Enterprises sells skincare and nutrition products through distributors to consumers.
- Market value
- $236m
- Cash yield
- 19.5%
- Price to profit
- 3.1×
- Return on capital
- 5.1%
- Funds
- 1
- Score
- 0.88
- Merck &MRK
Merck sells medicines, vaccines, and animal health products to wholesalers, hospitals, doctors and governments.
- Market value
- $355.1bn
- Cash yield
- 3.5%
- Price to profit
- n/a
- Return on capital
- n/a
- Funds
- 3
- Score
- 0.87
- ZoetisZTS
ZTS sells animal medicines and vaccines to pet owners, veterinarians, and livestock producers.
- Market value
- $30.2bn
- Cash yield
- 7.6%
- Price to profit
- n/a
- Return on capital
- n/a
- Funds
- 2
- Score
- 0.82
- Globus MedicalGMED
Surgical & medical instruments & apparatus
- Market value
- $10.0bn
- Cash yield
- 5.9%
- Price to profit
- 19.7×
- Return on capital
- n/a
- Funds
- 0
- Score
- 0.82
- BiogenBIIB
Biological products, (no diagnostic substances)
- Market value
- $32.1bn
- Cash yield
- 6.4%
- Price to profit
- 12.5×
- Return on capital
- 22.8%
- Funds
- 2
- Score
- 0.81
- Option Care HealthOPCH
Option Care Health provides home infusion therapy to patients with long-term illnesses.
- Market value
- $3.5bn
- Cash yield
- 6.2%
- Price to profit
- 13.1×
- Return on capital
- 10.0%
- Funds
- 0
- Score
- 0.80
- ConmedCNMD
CNMD sells surgical devices and services to hospitals, surgical centers, and doctors.
- Market value
- $1.4bn
- Cash yield
- 10.9%
- Price to profit
- 17.5×
- Return on capital
- n/a
- Funds
- 2
- Score
- 0.79
- MedtronicMDT
Medtronic sells medical devices and equipment to hospitals and clinics.
- Market value
- $116.4bn
- Cash yield
- 4.7%
- Price to profit
- 21.1×
- Return on capital
- n/a
- Funds
- 3
- Score
- 0.79
- PfizerPFE
Pfizer sells medicines and vaccines to patients, doctors, and governments.
- Market value
- $158.0bn
- Cash yield
- 5.7%
- Price to profit
- n/a
- Return on capital
- n/a
- Funds
- 4
- Score
- 0.77
- HerbalifeHLF
Herbalife sells nutrition products through independent members to consumers around the world.
- Market value
- $1.3bn
- Cash yield
- 20.1%
- Price to profit
- 6.0×
- Return on capital
- 26.1%
- Funds
- 2
- Score
- 0.76
- EmbectaEMBC
Embecta sells pen needles, syringes, and injection devices to people with diabetes.
- Market value
- $280m
- Cash yield
- 65.2%
- Price to profit
- 6.0×
- Return on capital
- 25.9%
- Funds
- 0
- Score
- 0.75
- MiMedx GroupMDXG
MDXG sells wound care products to clinicians treating hard-to-heal wounds.
- Market value
- $666m
- Cash yield
- 3.7%
- Price to profit
- 8.1×
- Return on capital
- 15.4%
- Funds
- 1
- Score
- 0.73
- InModeINMD
Electromedical & electrotherapeutic apparatus
- Market value
- $944m
- Cash yield
- 8.9%
- Price to profit
- 7.5×
- Return on capital
- n/a
- Funds
- 0
- Score
- 0.73
- Zimmer Biomet HoldingsZBH
Zimmer Biomet sells knee and hip replacements to hospitals and surgeons.
- Market value
- $17.8bn
- Cash yield
- 8.3%
- Price to profit
- 22.0×
- Return on capital
- 4.4%
- Funds
- 3
- Score
- 0.72
| Company | What they do | Market value | Cash yield | Price to profit | Return on capital | Funds | Score | |
|---|---|---|---|---|---|---|---|---|
| DavitaDVA | DaVita provides dialysis and kidney care services to people with kidney disease. | $11.6bn | 11.3% | 7.5× | n/a | 3 | 1.22 | See why |
| InnovivaINVA | Innoviva sells hospital drugs to hospitals and earns royalties from GSK. | $1.5bn | 13.1% | 7.3× | 20.7% | 2 | 1.15 | See why |
| Boston ScientificBSX | BSX sells medical devices to hospitals, doctors, and healthcare providers. | $62.3bn | 5.9% | 17.8× | n/a | 3 | 1.05 | See why |
| ExelixisEXEL | Exelixis sells cancer drugs to patients with kidney, liver, and colorectal cancer. | $13.9bn | 6.3% | 15.4× | n/a | 2 | 1.05 | See why |
| Harmony Biosciences Holdings, inc.HRMY | Harmony Biosciences sells narcolepsy medicine to patients with sleep disorders. | $2.4bn | 14.4% | 8.7× | 18.3% | 0 | 1.00 | See why |
| Puma BiotechnologyPBYI | Puma Biotechnology sells cancer drugs to patients with HER2-positive breast cancer. | $471m | 8.9% | 11.8× | 21.5% | 1 | 0.98 | See why |
| Nutex HealthNUTX | Nutex Health sells hospital and doctor care to patients and insurers. | $1.4bn | 17.9% | 4.4× | 60.7% | 1 | 0.96 | See why |
| Amphastar PharmaceuticalsAMPH | Amphastar sells generic injectable, inhalation, and nasal medicines to hospitals and patients. | $1.0bn | 12.0% | 10.4× | n/a | 0 | 0.95 | See why |
| ResMedRMD | ResMed sells sleep apnea devices, ventilators, masks, and software to patients, clinics, and hospitals. | $31.5bn | 5.2% | 16.5× | n/a | 2 | 0.93 | See why |
| GE Healthcare TechnologiesGEHC | GE HealthCare sells medical devices, software, and services to hospitals and researchers. | $28.9bn | 5.2% | 12.3× | 11.8% | 1 | 0.90 | See why |
| Prestige Consumer HealthcarePBH | PBH sells packaged foods and cereals to grocery retailers and consumers. | $2.2bn | 11.1% | 10.6× | 8.5% | 0 | 0.89 | See why |
| NU Skin EnterprisesNUS | Nu Skin Enterprises sells skincare and nutrition products through distributors to consumers. | $236m | 19.5% | 3.1× | 5.1% | 1 | 0.88 | See why |
| Merck &MRK | Merck sells medicines, vaccines, and animal health products to wholesalers, hospitals, doctors and governments. | $355.1bn | 3.5% | n/a | n/a | 3 | 0.87 | See why |
| ZoetisZTS | ZTS sells animal medicines and vaccines to pet owners, veterinarians, and livestock producers. | $30.2bn | 7.6% | n/a | n/a | 2 | 0.82 | See why |
| Globus MedicalGMED | Surgical & medical instruments & apparatus | $10.0bn | 5.9% | 19.7× | n/a | 0 | 0.82 | See why |
| BiogenBIIB | Biological products, (no diagnostic substances) | $32.1bn | 6.4% | 12.5× | 22.8% | 2 | 0.81 | See why |
| Option Care HealthOPCH | Option Care Health provides home infusion therapy to patients with long-term illnesses. | $3.5bn | 6.2% | 13.1× | 10.0% | 0 | 0.80 | See why |
| ConmedCNMD | CNMD sells surgical devices and services to hospitals, surgical centers, and doctors. | $1.4bn | 10.9% | 17.5× | n/a | 2 | 0.79 | See why |
| MedtronicMDT | Medtronic sells medical devices and equipment to hospitals and clinics. | $116.4bn | 4.7% | 21.1× | n/a | 3 | 0.79 | See why |
| PfizerPFE | Pfizer sells medicines and vaccines to patients, doctors, and governments. | $158.0bn | 5.7% | n/a | n/a | 4 | 0.77 | See why |
| HerbalifeHLF | Herbalife sells nutrition products through independent members to consumers around the world. | $1.3bn | 20.1% | 6.0× | 26.1% | 2 | 0.76 | See why |
| EmbectaEMBC | Embecta sells pen needles, syringes, and injection devices to people with diabetes. | $280m | 65.2% | 6.0× | 25.9% | 0 | 0.75 | See why |
| MiMedx GroupMDXG | MDXG sells wound care products to clinicians treating hard-to-heal wounds. | $666m | 3.7% | 8.1× | 15.4% | 1 | 0.73 | See why |
| InModeINMD | Electromedical & electrotherapeutic apparatus | $944m | 8.9% | 7.5× | n/a | 0 | 0.73 | See why |
| Zimmer Biomet HoldingsZBH | Zimmer Biomet sells knee and hip replacements to hospitals and surgeons. | $17.8bn | 8.3% | 22.0× | 4.4% | 3 | 0.72 | See why |
97 more match your filters
A free account shows the full list, remembers these filters, and emails you when a new company enters them. No card.